In animal tests, vaccine gives broad protection

The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology's make-or-break moment.

Tests of 10 or more novel vaccines could be underway by mid-May

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine

[Ottawa] : Health Canada = Santé Canada, [2020]

If successful, Pfizer said it hopes to receive emergency use authorization from the U.S. Food and Drug Administration as early as October

Italy claims to have developed the first COVID-19 vaccine: Here is what we know about all the potential coronavirus vaccines

China conducts 1st Covid vaccine test on monkeys

The vaccine was able to induce specific neutralising antibodies in all three animal models tested

Interview with Irene M. Shui, ScD, author of Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants

Interview with Björn Pasternak, MD, PhD, author of Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

Interview with Lara K. Misegades, PhD, MS, author of Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

Interview with Simon R. M. Dobson, MD, author of Immunogenicity of 2 Doses of Human Papillomavirus Vaccine in Younger Adolescents Versus 3 Doses in Young Women: A Randomized Clinical Trial

Interview with Lisen Arnheim-Dahlström, PhD, author of Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma

Interview with Mark J. Mulligan, MD, author of Emergency Postexposure Vaccination With Vesicular Stomatitis Virus-Vectored Ebola Vaccine After Needlestick

Interview with Anjali Jain, MD, author of Autism Occurrence by MMR Vaccine Status Among US Children With Older Siblings With and Without Autism

Interview with Saad B. Omer, MBBS, MPH, PhD, author of Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States A Review of Measles and Pertussis

As COVID-19 spreads globally, populations who survive their illness will become immune. Mayo Vaccine Research Group Director Gregory Poland, MD, discusses antibody responses, duration of immunity, vaccine safety, and the prospects for using convalescent serum to passively immunize people unexposed to SARS-CoV-2.

Hayden Library - QR201.T6 T83 2018

Hayden Library - QR189.5.P36 G69 2018

Online Resource

The pair hopes to stimulate the immune system to tackle tumors bearing mutant KRas proteins, one of cancer’s toughest targets

The first goal is to thwart the outbreak, but researchers also hope for new insights into combating the virus

With vaccines of some firms already in animal trial phase, developers say that if all goes well, India could have a vaccine by next year. The move comes at a time when Chinese research firms are entering phase II of clinical trials in a global race to find a vaccine for COVID-19.

'The challenge will be making sure its efficacy is high.' 'If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.'

'The challenge will be making sure its efficacy is high.'